MCID: CRC034
MIFTS: 19

Carcinoma Showing Thymus-Like Differentiation

Categories: Cancer diseases, Rare diseases

Aliases & Classifications for Carcinoma Showing Thymus-Like Differentiation

MalaCards integrated aliases for Carcinoma Showing Thymus-Like Differentiation:

Name: Carcinoma Showing Thymus-Like Differentiation 53
Castle 53

Classifications:



Summaries for Carcinoma Showing Thymus-Like Differentiation

MalaCards based summary : Carcinoma Showing Thymus-Like Differentiation, also known as castle, is related to thymoma and pernicious anemia. The drugs Lenograstim and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include thymus, thyroid and breast.

Related Diseases for Carcinoma Showing Thymus-Like Differentiation

Diseases related to Carcinoma Showing Thymus-Like Differentiation via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 36)
# Related Disease Score Top Affiliating Genes
1 thymoma 10.5
2 pernicious anemia 10.3
3 squamous cell carcinoma 10.2
4 familial adenomatous polyposis 10.1
5 atrial fibrillation 10.1
6 thymus cancer 10.0
7 lymphoepithelioma-like carcinoma 10.0
8 breast cancer 10.0
9 colorectal cancer 10.0
10 pancreatic agenesis 1 10.0
11 burns 10.0
12 alzheimer disease 9.8
13 arteries, anomalies of 9.8
14 bladder cancer 9.8
15 prostate cancer 9.8
16 strabismus 9.8
17 lung cancer 9.8
18 pancreatic cancer 9.8
19 blood group--swann system 9.8
20 brittle bone disorder 9.8
21 late-onset retinal degeneration 9.8
22 anxiety 9.8
23 myelodysplastic syndrome 9.8
24 leukemia 9.8
25 pemphigus foliaceus 9.8
26 peripheral artery disease 9.8
27 mastitis 9.8
28 shigellosis 9.8
29 thyroid cancer 9.8
30 macrocytic anemia 9.8
31 bilirubin metabolic disorder 9.8
32 persian gulf syndrome 9.8
33 adenoma 9.8
34 myeloid leukemia 9.8
35 pemphigus 9.8
36 desmoplastic infantile astrocytoma 9.8

Graphical network of the top 20 diseases related to Carcinoma Showing Thymus-Like Differentiation:



Diseases related to Carcinoma Showing Thymus-Like Differentiation

Symptoms & Phenotypes for Carcinoma Showing Thymus-Like Differentiation

Drugs & Therapeutics for Carcinoma Showing Thymus-Like Differentiation

Drugs for Carcinoma Showing Thymus-Like Differentiation (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 480)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2 135968-09-1
2
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
3
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2 302-25-0
4
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2 2921-57-5
5
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
6 tannic acid Approved Phase 4,Phase 3
7
Benzocaine Approved, Investigational Phase 4,Phase 3 94-09-7, 1994-09-7 2337
8
Ticagrelor Approved Phase 4 274693-27-5 9871419
9
Nitric Oxide Approved Phase 4 10102-43-9 145068
10
Montelukast Approved Phase 4 158966-92-8 5281040
11
Valproic Acid Approved, Investigational Phase 4 99-66-1 3121
12
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
13
Pravastatin Approved Phase 4,Phase 3 81093-37-0 54687
14
Simvastatin Approved Phase 4 79902-63-9 54454
15
Rabeprazole Approved, Investigational Phase 4 117976-89-3 5029
16
Esomeprazole Approved, Investigational Phase 4 161796-78-7, 119141-88-7 4594 9579578
17
Morphine Approved, Investigational Phase 4,Not Applicable 57-27-2 5288826
18
Warfarin Approved Phase 4,Phase 3,Phase 1,Not Applicable 81-81-2 6691 54678486
19
Amlodipine Approved Phase 4,Phase 3 88150-42-9 2162
20
Angiotensin II Approved, Investigational Phase 4,Phase 3 11128-99-7, 68521-88-0, 4474-91-3 172198 65143
21
Olmesartan Approved, Investigational Phase 4,Phase 3 144689-63-4, 144689-24-7 158781 130881
22
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
23
Metformin Approved Phase 4,Phase 3,Phase 2 657-24-9 14219 4091
24
Pioglitazone Approved, Investigational Phase 4,Phase 3 111025-46-8 4829
25
Iron Approved Phase 4,Phase 3 7439-89-6 23925
26
Repaglinide Approved, Investigational Phase 4 135062-02-1 65981
27
Nateglinide Approved, Investigational Phase 4 105816-04-4 60026
28
Atezolizumab Approved, Investigational Phase 4,Phase 2,Phase 3 1380723-44-3
29
Serine Approved, Nutraceutical Phase 4,Phase 3 56-45-1 5951
30
Prednisolone hemisuccinate Experimental Phase 4,Phase 3,Phase 2 2920-86-7
31 Tranquilizing Agents Phase 4,Phase 2,Phase 3,Phase 1
32 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
33 Antipsychotic Agents Phase 4,Phase 2,Phase 3
34 Quetiapine Fumarate Phase 4 111974-72-2
35 Psychotropic Drugs Phase 4,Phase 2,Phase 3,Phase 1
36 Adjuvants, Immunologic Phase 4,Phase 3
37 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
38 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Protective Agents Phase 4,Phase 3,Phase 2
40 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
41 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
42 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
43 Methylprednisolone acetate Phase 4,Phase 3,Phase 2
44 Prednisolone acetate Phase 4,Phase 3,Phase 2
45 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
46 Neuroprotective Agents Phase 4,Phase 3,Phase 2
47 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1
48 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
49 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
50 Antiemetics Phase 4,Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 352)
# Name Status NCT ID Phase Drugs
1 Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry Unknown status NCT00986167 Phase 4 Quetiapine XR
2 Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer Unknown status NCT00030758 Phase 4
3 Catheter Ablation vs. Standard Conventional Treatment in Patients With LV Dysfunction and AF Completed NCT00643188 Phase 4
4 Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide? Completed NCT02169596 Phase 4
5 The Utility of feNO in the Differential Diagnosis of Chronic Cough Completed NCT02479074 Phase 4 Montelukast (High FeNO group);Prednisolon, Montelukast (High FeNO);Montelukast (Low FeNO group)
6 Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different Settings Completed NCT00685035 Phase 4
7 ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness Completed NCT00484471 Phase 4 aripiprazole;valproate;placebo
8 Conservative Non-Invasive Versus Routine Invasive Management in Coronary Artery Bypass Surgery Patients With Non ST Elevation Elevation Acute Coronary Syndrome Completed NCT01895751 Phase 4
9 A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks. Completed NCT00755352 Phase 4 pravastatin tablets and Welchol tablets;pravastatin tablets and Welchol placebo tablets
10 A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks. Completed NCT00754507 Phase 4 colesevelam HCl tablets, and atorvastatin tablets;colesevelam HCl placebo tablets and atorvastatin tablets
11 A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Simvastatin for at Least 4 Weeks. Completed NCT00753779 Phase 4 colesevelam HCl tablets, and simvastatin tablets;simvastatin tablets and colesevelam HCl placebo
12 A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg Completed NCT00464308 Phase 4 Esomeprazole;Rabeprazole;Esomeprazole
13 Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza Completed NCT00640042 Phase 4 morphine sulfate extended release capsules
14 Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT) Completed NCT02348723 Phase 4 Warfarin;Dabigatran Etexilate 150mg
15 Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure Completed NCT00733343 Phase 4
16 Spontaneous Atrio Ventricular Conduction Preservation Completed NCT00655213 Phase 4
17 Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension Completed NCT00311155 Phase 4 olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary
18 A Pragmatic Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE Study) Recruiting NCT02616666 Phase 4 Dapagliflozin;Standard of Care
19 Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN Recruiting NCT02642562 Phase 4 Iron (III) isomaltoside 1000
20 A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Recruiting NCT03285763 Phase 4 Atezolizumab
21 Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) Withdrawn NCT01176318 Phase 4 Erdosteine;Placebo
22 Radiation Therapy or Standard Therapy in Treating Women With Stage II Breast Cancer Who Have Undergone Mastectomy Unknown status NCT00966888 Phase 3
23 A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females Unknown status NCT00547469 Phase 2, Phase 3 DDP733
24 A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients Unknown status NCT01303887 Phase 3 Rituximab;Cyclophosphamide;Vincristine;Prednisolone;Fludarabine
25 Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer Unknown status NCT00002460 Phase 3 goserelin acetate;tamoxifen citrate
26 Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer Unknown status NCT00450203 Phase 2, Phase 3 capecitabine;cisplatin;Epirubicin;Lapatinib
27 Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery Unknown status NCT00039546 Phase 3 cyclophosphamide;epirubicin hydrochloride;gemcitabine hydrochloride;paclitaxel
28 Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation Unknown status NCT00033475 Phase 3
29 CASTLE (Clopidogrel And Serum Troponin Level Elevation) Completed NCT00716924 Phase 3 Clopidogrel;Clopidogrel
30 Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia Completed NCT00002868 Phase 3 busulfan;cytarabine;etoposide;hydroxyurea;idarubicin
31 Study of the Safety and Effectiveness of BC1036 Capsules to Treat Frequent Long-Term Cough Completed NCT01656668 Phase 3 BC1036
32 Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease Completed NCT01513460 Phase 3 NVA237 50µg once daily;Tiotropium 18µg once daily;Flu/Sal;NVA237 placebo + Tiotropium placebo.
33 Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza Completed NCT02612922 Phase 3 Nitazoxanide;Placebo
34 Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza Completed NCT01610245 Phase 3 Nitazoxanide;Oseltamivir;Placebo Oral Tablet;Placebo Oral Capsule
35 Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Completed NCT01479244 Phase 3
36 Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke Completed NCT00790920 Phase 3 Desmoteplase;Placebo
37 Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne Completed NCT00656981 Phase 3 YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300);Placebo
38 Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension Completed NCT00527514 Phase 3 Amlodipine;Olmesartan medoxomil plus amlodipine
39 Study of Safety and Efficacy of an Oral Contraceptive Completed NCT00477633 Phase 3 Norethindrone/ethinyl estradiol
40 Efficacy and Safety Study of an Oral Contraceptive in Healthy Females Completed NCT00206583 Phase 3 EV/DNG (Qlaira, BAY86-5027, SH T00658ID)
41 Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Completed NCT00884741 Phase 3 Temozolomide
42 Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone Completed NCT00121667 Phase 3 Saxagliptin + Metformin;Saxagliptin + Metformin;Saxagliptin + Metformin;Placebo + Metformin;Pioglitazone
43 Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Completed NCT00121641 Phase 3 Saxagliptin;Saxagliptin;Saxagliptin;Placebo matching Saxagliptin;Metformin;Placebo matching Metformin;Saxagliptin;Metformin
44 Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors Completed NCT00566852 Phase 3 Memantine
45 Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer Completed NCT00365105 Phase 3 zoledronic acid;Sm-153
46 Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer Completed NCT00080340 Phase 3 TLK286 (Telcyta) HCl for Injection;gefitinib (Iressa)
47 Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer Completed NCT00052910 Phase 3 cisplatin;epirubicin hydrochloride;fluorouracil;leucovorin calcium
48 Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery Completed NCT00003901 Phase 3
49 Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer Completed NCT00003831 Phase 3
50 Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer Completed NCT00003354 Phase 3

Search NIH Clinical Center for Carcinoma Showing Thymus-Like Differentiation

Genetic Tests for Carcinoma Showing Thymus-Like Differentiation

Anatomical Context for Carcinoma Showing Thymus-Like Differentiation

MalaCards organs/tissues related to Carcinoma Showing Thymus-Like Differentiation:

41
Thymus, Thyroid, Breast, Bone, Prostate, Myeloid, Lung

Publications for Carcinoma Showing Thymus-Like Differentiation

Articles related to Carcinoma Showing Thymus-Like Differentiation:

(show top 50) (show all 294)
# Title Authors Year
1
Atrial fibrillation and heart failure- results of the CASTLE-AF trial. ( 30181827 )
2018
2
Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525-36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit. ( 30268660 )
2018
3
Shattering the castle walls: Anti-stromal therapy for pancreatic cancer. ( 30147846 )
2018
4
Management and Prognostic Factors for Thyroid Carcinoma Showing Thymus-Like Elements (CASTLE): A Case Series Study. ( 30416983 )
2018
5
CaSTLe - Classification of single cells by transfer learning: Harnessing the power of publicly available single cell RNA sequencing experiments to annotate new experiments. ( 30304022 )
2018
6
Correction: CaSTLe - Classification of single cells by transfer learning: Harnessing the power of publicly available single cell RNA sequencing experiments to annotate new experiments. ( 30481223 )
2018
7
CASTLE tumor of the parotid: First documented case, literature review, and genetic analysis of the cancer. ( 29120527 )
2018
8
The Impact of a Nursing Coping Kit and a Nursing Coping Bouncy Castle on the Medical Fear Levels of Uzbek Refugee Children. ( 29395790 )
2018
9
Robotic surgery in public hospitals of Latin-America: a castle of sand? ( 29459996 )
2018
10
Is there a CASTLE-AF on the hill? ( 29688436 )
2018
11
Catheter ablation of atrial fibrillation and outcomes in heart failure patients: seeking the treasure in the CASTLE. ( 29800377 )
2018
12
Massacre of Canadian Army Medical Corps personnel after the sinking of HMHS Llandovery Castle and the evolution of modern war crime jurisprudence. ( 29806812 )
2018
13
Huff and Puff, This CASTLE Is Made of Bricks. ( 29848751 )
2018
14
Retracted: Addition of a single methyl group to a small molecule sodium channel inhibitor introduces a new mode of gating modulation, by L Wang, SG Zellmer, DM Printzenhoff and NA Castle. British Journal of Pharmacology, volume 172(20): 4905-4918, published in October 2015; DOI 10.1111/bph.13259. ( 29906330 )
2018
15
Rothenfels Castle - the place to be for immunology of infection. ( 29974952 )
2018
16
The microbiomes of a XVIII century mummy from the castle of Krásna Hôrka (Slovakia) and its surrounding environment. ( 30051567 )
2018
17
Effect size in CASTLE-AF trial: the issue of 'the tiny effect'. ( 30054372 )
2018
18
Outcome of Thyroid Carcinoma Showing Thymus-Like Differentiation in Patients Undergoing Radical Resection. ( 29134304 )
2017
19
"A man's home is his castle and fortress": Effect of age on the psychological distress associated with house damage following super typhoon Haiyan. ( 28119175 )
2017
20
Lactoferrin researchers descend on Nagoya Castle. ( 28186858 )
2017
21
A key to the backdoor into the castle: The clinical ramifications of immunoediting driven by antigenic competition. ( 28340323 )
2017
22
A Greek physician's portrait in Windsor Castle. ( 28382829 )
2017
23
High radiofrequency radiation at Stockholm Old Town: An exposimeter study including the Royal Castle, Supreme Court, three major squares and the Swedish Parliament. ( 28413651 )
2017
24
Abstracts of the 25th European Workshop on Neonatology, Westerburg Castle, Germany, May 28th - 31st, 2017. ( 28453494 )
2017
25
The need for MR conditional devices: a sand castle at the seashore? ( 28455272 )
2017
26
Vertebral Artery Dissection in a Bouncy Castle Injury: Case Report and Literature Review. ( 28554184 )
2017
27
2017 Keystone Symposia at the Fairmont Banff Springs: Exploring new concepts in innate immunity and interferon signaling at the haunted castle. ( 28576287 )
2017
28
Re: Castle, et al., 2017; Diabetes Technol Ther; DOI: 10.1089/dia.2017.0012. ( 28704065 )
2017
29
Behavioural neuroscience: King of the castle. ( 28775340 )
2017
30
Correspondence regarding Castle., Human papillomavirus screening for low and middle-income countries. ( 28780060 )
2017
31
Surgical management of primary and recurrent carcinoma showing thymous-like elements (CASTLE). ( 28874619 )
2017
32
CASTLE Thyroid Tumor: A Case Report and Literature Review. ( 28955658 )
2017
33
Clinical analysis of 82 cases of carcinoma showing thymus-like differentiation of the thyroid. ( 26893738 )
2016
34
CT and MR imaging of thyroid carcinoma showing thymus-like differentiation (CASTLE): a report of ten cases. ( 26954328 )
2016
35
Clinical outcome of intensity modulated radiotherapy for carcinoma showing thymus-like differentiation. ( 27626313 )
2016
36
Carcinoma Showing Thymus-Like Differentiation (CASTLE): Cytopathological Features and Differential Diagnosis. ( 27643719 )
2016
37
First radon measurements and occupational exposure assessments in underground geodynamic laboratory the Polish Academy of Sciences Space Research Centre in Książ Castle (SW Poland). ( 27814500 )
2016
38
Medicine and Charity in Eighteenth-century Northumberland: The Early Years of the Bamburgh Castle Dispensary and Surgery, c. 1772-1802. ( 27482145 )
2016
39
A giant anguilliform leptocephalus Thalassenchelys foliaceus Castle & Raju is a junior synonym of Congriscus maldivensis (Norman 1939). ( 27511812 )
2016
40
"Time Machine" at Monemvasia, a mediaeval castle city in Greece. ( 27564640 )
2016
41
Paul Castle. ( 27767138 )
2016
42
Chemosensitivity in Carcinoma Showing Thymus-Like Differentiation: A Case Report and Review of the Literature. ( 26061805 )
2015
43
Carcinoma showing thymus-like differentiation (CASTLE): Report of a case specified in the cytomorphology. ( 26296650 )
2015
44
Intrathyroidal Epithelial Thymoma: Carcinoma Showing Thymus-like Differentiation Mimicking Squamous Cell Carcinoma of the Thyroid. ( 25797868 )
2015
45
Thyroid carcinoma showing thymus-like differentiation with tracheal invasion. ( 26207002 )
2015
46
Determinants of mastitis in women in the CASTLE study: a cohort study. ( 26674724 )
2015
47
Anxiety disorders deserve an integrated systems approach - an interview with Prof David Castle. ( 26216797 )
2015
48
"The Castle of Remembrance": New insights from a cognitive training programme for autobiographical memory in Alzheimer's disease. ( 25122521 )
2015
49
Changes in bone mineral density after 96 weeks of treatment with atazanavir/ritonavir or lopinavir/ritonavir plus tenofovir DF/emtricitabine in treatment-naive patients with HIV-1 infection: the CASTLE body composition substudy. ( 25296097 )
2015
50
Reply to letter to the editor by Sue J. Goldie and Phil E. Castle regarding Evaluation of a cervicography-based program to ensure visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa by Firnhaber et al. ( 25811274 )
2015

Variations for Carcinoma Showing Thymus-Like Differentiation

Expression for Carcinoma Showing Thymus-Like Differentiation

Search GEO for disease gene expression data for Carcinoma Showing Thymus-Like Differentiation.

Pathways for Carcinoma Showing Thymus-Like Differentiation

GO Terms for Carcinoma Showing Thymus-Like Differentiation

Sources for Carcinoma Showing Thymus-Like Differentiation

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....